{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:26:11Z","timestamp":1740147971000,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology","award":["16K10346"],"award-info":[{"award-number":["16K10346"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12149-018-1304-6","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T04:20:25Z","timestamp":1537417225000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical feasibility of early scanning after administration of 68Ga-DOTATOC"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-8048","authenticated-orcid":false,"given":"Yuji","family":"Nakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"1304_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00259-012-2286-6","volume":"40","author":"D Putzer","year":"2013","unstructured":"Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, et al. Somatostatin receptor PET in neuroendocrine tumours: 68 Ga-DOTA0,Tyr3-octreotide versus 68 Ga-DOTA0-lanreotide. Eur J Nucl Med Mol Imaging. 2013;40:364\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1304_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2967\/jnumed.116.185587","volume":"58","author":"M Barrio","year":"2017","unstructured":"Barrio M, Czernin J, Fanti S, Ambrosini V, Binse I, Du L, et al. The impact of somatostatin receptor-directed PET\/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis. J Nucl Med. 2017;58:756\u201361.","journal-title":"J Nucl Med"},{"key":"1304_CR3","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","volume":"37","author":"I Virgolini","year":"2010","unstructured":"Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, et al. Procedure guidelines for PET\/CT tumour imaging with 68 Ga-DOTA-conjugated peptides: 68 Ga-DOTA-TOC, 68 Ga-DOTA-NOC, 68 Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37:2004\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1304_CR4","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","volume":"44","author":"MF Bozkurt","year":"2017","unstructured":"Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, et al. Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA. Eur J Nucl Med Mol Imaging. 2017;44:1588\u2013601.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1304_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2967\/jnumed.113.126177","volume":"55","author":"I Velikyan","year":"2014","unstructured":"Velikyan I, Sundin A, S\u00f6rensen J, Lubberink M, Sandstr\u00f6m M, Garske-Rom\u00e1n U, et al. Quantitative and qualitative intrapatient comparison of 68 Ga-DOTATOC and 68 Ga-DOTATATE: net uptake rate for accurate quantification. J Nucl Med. 2014;55:204\u201310.","journal-title":"J Nucl Med"},{"key":"1304_CR6","doi-asserted-by":"publisher","first-page":"1069.e1-5","DOI":"10.1016\/j.crad.2016.04.017","volume":"71","author":"Y Nakamoto","year":"2016","unstructured":"Nakamoto Y, Ishimori T, Sano K, Temma T, Ueda M, Saji H, et al. Clinical efficacy of dual-phase scanning using (68)Ga-DOTATOC-PET\/CT in the detection of neuroendocrine tumours. Clin Radiol. 2016;71:1069.e1-5.","journal-title":"Clin Radiol"},{"key":"1304_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11307-008-0159-y","volume":"10","author":"A Dirisamer","year":"2008","unstructured":"Dirisamer A, Halpern BS, Schima W, Heinisch M, Wolf F, Beheshti M, et al. Dual-time-point FDG-PET\/CT for the detection of hepatic metastases. Mol Imaging Biol. 2008;10:335\u201340.","journal-title":"Mol Imaging Biol"},{"key":"1304_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12149-012-0599-y","volume":"26","author":"KK Miyake","year":"2012","unstructured":"Miyake KK, Nakamoto Y, Togashi K. Dual-time-point 18F-FDG PET\/CT in patients with colorectal cancer: clinical value of early delayed scanning. Ann Nucl Med. 2012;26:492\u2013500.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-018-1304-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1304-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1304-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T19:22:52Z","timestamp":1568920972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-018-1304-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1007\/s12149-018-1304-6","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"assertion":[{"value":"15 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}